Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study

被引：1

作者：

Zhang Lu ^{[1
,2
,3
,4
]}

Liu YiXuan ^{[1
,2
,3
,4
]}

Wang Zhe ^{[5
,6
,7
,8
,9
,4
]}

Wang XiaoQi ^{[5
,6
,7
,8
,9
,4
]}

Zhang JingJing ^{[1
,2
,3
,4
]}

Jiang RongHuan ^{[10
,11
,8
,3
,4
,12
,13
,14
,4
]}

Wang XiangQun ^{[10
,11
,8
,3
,4
]}

Zhu ShiWei ^{[1
,2
,3
,4
]}

Wang Kun ^{[1
,2
,3
,4
]}

Liu ZuoJing ^{[1
,2
,3
,4
]}

Zhu HuaiQiu ^{[5
,6
,7
,8
,9
,4
]}

Duan LiPing

机构：

[1] DepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing100191,ChinaDepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing100191,ChinaDepartmentofBiomedicalEngineering,CollegeofEngineering,andCenterforQuantitativeBiology,PekingUnivers

[2] DepartmentofPsychologicalMedicine,ChinesePeople’sLiberationArmy(PLA)GeneralHospital,Beijing100853,ChinaDepartmentofPsychiatry,InstituteofMentalHealth,PekingUniversity,Beijing100191,ChinaDepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing1001

来源：

中华医学杂志英文版 | 2019年 / 132卷 / 03期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>To the Editor: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder that presents as abdominal pain with altered bowel habits. The pathophysiologic mechanism of IBS is no

引用

页码：346 / 347-348-349-350-351

共 50 条

[31] Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome
Li, Ying
Hong, Gaichao
Yang, Min
Li, Gangping
Jin, Yu
Xiong, Hanhua
Qian, Wei
Hou, Xiaohua
PHARMACOLOGICAL RESEARCH, 2020, 159
[32] Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
Wang Zhe
Xu Cong-Min
Liu Yi-Xuan
Wang Xiao-Qi
Zhang Lu
Li Mo
Zhu Shi-Wei
Xie Zhong-Jie
Wang Pei-Hong
Duan Li-Ping
Zhu Huai-Qiu
中华医学杂志英文版, 2019, 132 (08) : 889 - 904
[33] Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Lijun Mei
Jiaoli Zhou
Yimo Su
Kunhong Mao
Jing Wu
Caicai Zhu
Ling He
Ying Cui
BMC Gastroenterology, 21
[34] Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Mei, Lijun
Zhou, Jiaoli
Su, Yimo
Mao, Kunhong
Wu, Jing
Zhu, Caicai
He, Ling
Cui, Ying
BMC GASTROENTEROLOGY, 2021, 21 (01)
[35] Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: A pilot study
Xiao, WB
Liu, YL
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (02) : 312 - 319
[36] Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Carroll, Ian M.
Chang, Young-Hyo
Park, Jiwon
Sartor, R. Balfour
Ringel, Yehuda
GUT PATHOGENS, 2010, 2
[37] Clinical Pearls for Irritable Bowel Syndrome Management of the Diarrhea-Predominant Subtype
Lacy, Brian E.
O'Shana, Tracia
GASTROENTEROLOGY NURSING, 2014, 37 (06) : 392 - 405
[38] Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Ian M Carroll
Young-Hyo Chang
Jiwon Park
R Balfour Sartor
Yehuda Ringel
Gut Pathogens, 2
[39] Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Sobolewska-Wlodarczyk, Aleksandra
Wlodarczyk, Marcin
Storr, Martin
Fichna, Jakub
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 771 - 775
[40] Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels
Mazzawi, Tarek
Hausken, Trygve
Hov, Johannes R.
Valeur, Jorgen
Sangnes, Dag Andre
El-Salhy, Magdy
Gilja, Odd Helge
Hatlebakk, Jan Gunnar
Lied, Gulen Arslan
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 690 - 699

← 1 2 3 4 5 →